AstraZeneca Launches At-Home Nasal Flu Vaccine

J. Carlisle Larsen outlines FluMist Home's FDA approval for at-home use, ordering process, age limits, and expected insurance coverage.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!